Skip to main content
Clinical Trials/NCT02146677
NCT02146677
Unknown
Not Applicable

Effect of Osteopathic Manipulative Treatment on Pain in Preterms

European Institute for Evidence Based Osteopathic Medicine1 site in 1 country120 target enrollmentJune 2014
ConditionsPrematurity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prematurity
Sponsor
European Institute for Evidence Based Osteopathic Medicine
Enrollment
120
Locations
1
Primary Endpoint
changes from baseline in pain using Premature Infant Pain Profile (PIPP)
Last Updated
11 years ago

Overview

Brief Summary

Osteopathic manipulative treatment (OMT) has been used to treat term and preterm newborns. Recent studies demonstrated the effectiveness of OMT in reducing length of stay and costs (Cerritelli, 2013) as well as the likelihood of gastrointestinal episodes (Pizzolorusso 2011). Moreover it was reported the absence of adverse events and side effects considering the approach safe (Cerritelli 2013, 2014).

OMT was extensively used to treat, prevent and manage pain symptoms. Numerous research was published addressing acute and chronic pain in different medical conditions. However, no trials were carried out on pain in newborns. The aim of the present clinical trial is to explore the effectiveness of OMT in reducing pain in a sample of preterm infants.

Registry
clinicaltrials.gov
Start Date
June 2014
End Date
September 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
European Institute for Evidence Based Osteopathic Medicine
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • preterm infants
  • written informed consent by parents or legal guardians
  • preterms born in the same hospital

Exclusion Criteria

  • Gestational age \> 37 weeks
  • genetic disorders
  • congenital disorders
  • cardiovascular abnormalities
  • proven or suspected necrotized enterocolitis with or without gastrointestinal perforation
  • proven or suspected abdominal obstruction
  • pre/post surgery patients
  • pneumoperitoneum
  • atelectasis
  • Newborn from an HIV seropositive/drug addicted mother

Outcomes

Primary Outcomes

changes from baseline in pain using Premature Infant Pain Profile (PIPP)

Time Frame: baseline and end of hospitalization, average length of hospitalization expected 4 weeks

Secondary Outcomes

  • Number of days of length of stay(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)

Study Sites (1)

Loading locations...

Similar Trials